Cannabis for endometriosis-related pain and symptoms: It's high time that we see this as a legitimate treatment
- PMID: 36691911
- DOI: 10.1111/ajo.13642
Cannabis for endometriosis-related pain and symptoms: It's high time that we see this as a legitimate treatment
Similar articles
-
Is it the Ideal Time to Start Prescribing Cannabis Derivatives to Treat Endometriosis-associated Pain?Rev Bras Ginecol Obstet. 2022 May;44(5):449-451. doi: 10.1055/s-0042-1749430. Epub 2022 Jun 13. Rev Bras Ginecol Obstet. 2022. PMID: 35697067 Free PMC article. No abstract available.
-
Botulinum Toxin to Treat Endometriosis Pain.JAMA. 2019 Aug 27;322(8):716. doi: 10.1001/jama.2019.12350. JAMA. 2019. PMID: 31454029 No abstract available.
-
Cannabidiol for the Management of Endometriosis and Chronic Pelvic Pain.J Minim Invasive Gynecol. 2022 Feb;29(2):169-176. doi: 10.1016/j.jmig.2021.11.017. Epub 2021 Nov 25. J Minim Invasive Gynecol. 2022. PMID: 34839061 Review.
-
Treatment of endometriosis.N Engl J Med. 2001 Jul 26;345(4):266-75. doi: 10.1056/NEJM200107263450407. N Engl J Med. 2001. PMID: 11474666 Review. No abstract available.
-
Elagolix, a novel, orally bioavailable GnRH antagonist under investigation for the treatment of endometriosis-related pain.Womens Health (Lond). 2015 Jan;11(1):19-28. doi: 10.2217/whe.14.68. Womens Health (Lond). 2015. PMID: 25581052 Review.
Cited by
-
The Place of Cannabinoids in the Treatment of Gynecological Pain.Drugs. 2023 Nov;83(17):1571-1579. doi: 10.1007/s40265-023-01951-z. Epub 2023 Oct 13. Drugs. 2023. PMID: 37831340 Free PMC article.
-
Non-response to first-line hormonal treatment for symptomatic endometriosis: overcoming tunnel vision. A narrative review.BMC Womens Health. 2023 Jun 30;23(1):347. doi: 10.1186/s12905-023-02490-1. BMC Womens Health. 2023. PMID: 37391793 Free PMC article. Review.
-
Cannabis and Endometriosis: The Roles of the Gut Microbiota and the Endocannabinoid System.J Clin Med. 2023 Nov 13;12(22):7071. doi: 10.3390/jcm12227071. J Clin Med. 2023. PMID: 38002684 Free PMC article. Review.
References
REFERENCES
-
- Rowlands IJ, Abbott JA, Montgomery GW et al. Prevalence and incidence of endometriosis in Australian women: A data linkage cohort study. BJOG 2021; 128(4): 657-665.
-
- Armour M, Lawson K, Wood A et al. The cost of illness and economic burden of endometriosis and chronic pelvic pain in Australia: A national online survey. PLoS One 2019; 14(10): e0223316.
-
- Sinaii N, Cleary SD, Younes N et al. Treatment utilization for endometriosis symptoms: A cross-sectional survey study of lifetime experience. Fertil Steril 2007; 87(6): 1277-1286.
-
- As-Sanie S, Soliman AM, Evans K et al. Healthcare utilization and cost burden among women with endometriosis by opioid prescription status in the first year after diagnosis: A retrospective claims database analysis. J Med Econ 2020; 23(4): 371-377.
-
- Chiuve SE, Kilpatrick RD, Hornstein MD et al. Chronic opioid use and complication risks in women with endometriosis: A cohort study in US administrative claims. Pharmacoepidemiol Drug Saf 2021; 30: 787-796.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical